Simplicity Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Buy
12,229
+725
+6% +$41.6K 0.02% 531
2026
Q1
$698K Buy
11,504
+2,340
+26% +$136K 0.04% 370
2025
Q4
$494K Buy
9,164
+1,429
+18% +$68.7K 0.03% 431
2025
Q3
$349K Sell
7,735
-2,173
-22% -$101K 0.02% 524
2025
Q2
$459K Buy
9,908
+5,556
+128% +$273K 0.02% 477
2025
Q1
$265K Buy
+4,352
New +$254K 0.02% 446
2024
Q3
– Sell
-37,880
Closed -$1.57M – 567
2024
Q2
$1.57M Sell
37,880
-25,311
-40% -$1.13M 0.04% 402
2024
Q1
$3.43M Buy
+63,191
New +$3.22M 0.08% 242

Other funds holding BMY

Simplicity Wealth's BMY Position: Q2 2026 in Review

Simplicity Wealth increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2026, buying an estimated $41.6K and bringing the position to 12,229 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #531.

Simplicity Wealth first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.43M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Simplicity Wealth held 12,229 shares of Bristol-Myers Squibb worth $705K as of Q2 2026.
  • Simplicity Wealth bought 725 Bristol-Myers Squibb shares in Q2 2026, an estimated $41.6K.
  • Bristol-Myers Squibb made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #531 holding.
  • Simplicity Wealth first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
  • Simplicity Wealth's Bristol-Myers Squibb position peaked at $3.43M in Q1 2024.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.